FN2 Earnings Intelligence

Amgen Inc. financials (quarterly)

Amgen Inc. (AMGN) Key Stats (quarterly) derived from persisted SEC financial facts.

Key Stats

USD in millions, except per-share values and percentages.

Metric 9/30/20243/31/20256/30/20259/30/20253/31/2026
Market Cap -----
- Cash $9,011$8,810$8,028$9,445$12,038
+ Debt -----
Enterprise Value -----
Revenue $8,503$8,149$9,179$9,557$8,618
% Growth -----
Gross Profit $5,193$5,181$6,168$6,475$5,874
% Margin 61.1%63.6%67.2%67.8%68.2%
EBITDA -$2,565$2,876$2,758$3,782
% Margin -31.5%31.3%28.9%43.9%
Net Income $2,830$1,730$1,432$3,216$1,819
% Margin 33.3%21.2%15.6%33.7%21.1%
Diluted EPS $5.22$3.20$2.65$5.93$3.34
% Growth -----
Operating Cash Flow -$1,391--$2,189
CapEx -$411--$712
Free Cash Flow -$980--$1,477

Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.